Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Kimberly Huhn

Physician Assistant East Lansing, MI Physician Assistant

NPI 1649472523 CMS profile 11038756

2852 Eyde Pkwy Ste 175, East Lansing, MI 48823

Open in the dashboard

General payments

$9,280

583 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kimberly Huhn of East Lansing, MI is reported in the CMS Open Payments database as having received $9,280 across 583 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,299 74
2024 General $1,673 91
2023 General $1,805 103
2022 General $2,367 159
2021 General $2,135 156

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kimberly Huhn
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Kimberly Huhn were reported at $1,299. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Kimberly Huhn Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $2,135 $132 $37–$438 $132
2022 $2,367 $155 $48–$522 $149
2023 $1,805 $167 $52–$557 $160
2024 $1,673 $178 $55–$600 $164
2025 $1,299 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $1,411 126 payments
  2. Novo Nordisk Inc $1,319 82 payments
  3. Pfizer Inc. $897 50 payments
  4. Amgen Inc. $708 54 payments
  5. AstraZeneca Pharmaceuticals LP $665 16 payments
  6. Lilly USA, LLC $505 36 payments
  7. GlaxoSmithKline, LLC. $302 23 payments
  8. Bayer HealthCare Pharmaceuticals Inc. $297 18 payments
  9. Averitas Pharma Inc. $271 14 payments
  10. Boehringer Ingelheim Pharmaceuticals, Inc. $195 9 payments
  11. Other $2,711 155 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $9,280 583 payments
Products named General payments · program years 2021–2025
  1. Ozempic $845 48 payments
  2. NURTEC ODT $708 38 payments
  3. UBRELVY $548 55 payments
  4. FARXIGA $525 7 payments
  5. VRAYLAR $494 47 payments
  6. BREZTRI $489 5 payments
  7. RYBELSUS $468 29 payments
  8. ZAVZPRET $464 25 payments
  9. QULIPTA $453 31 payments
  10. Otezla $428 40 payments
  11. Other $8,575 501 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 115 drugs

Part D claims

5,996

Median for Physician Assistant: 241

Drug cost

$704,456

Median for Physician Assistant: $4,110

Branded share of claims

23.4%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ozempic Semaglutide Brand 84 $136,295
Jardiance Empagliflozin Brand 67 $106,681
Trelegy Ellipta Fluticasone/Umeclidin/Vilanter Brand 50 $71,032
Eliquis Apixaban Brand 41 $62,591
Trulicity Dulaglutide Brand 14 $34,488
Mounjaro Tirzepatide Brand 23 $31,941
Myrbetriq Mirabegron Brand 33 $30,785
Xarelto Rivaroxaban Brand 25 $28,189
Farxiga Dapagliflozin Propanediol Brand 18 $23,596
Tresiba Flextouch U-200 Insulin Degludec Brand 13 $19,068

The 10 drugs with the highest cost, of 115 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 10 billing codes

Paid by Medicare

$1,008

Medicare's payments for the services billed

Medicare patients

20

Average age 73

Services billed

28

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 65%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 32 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
NURTEC ODT
$132 — —
VRAYLAR
$128 11 —
Ozempic
$112 84 —
Nayzilam
$91 — —
ZAVZPRET
$89 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 32 with Patron

Records

583 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record